Bioeq IP AG’s Lucentis Biosimilar Out-Licensing To Coherus BioSciences, Inc.

Paolo Bossi Europe, Europe Legal Chronicle

Freshfields Bruckhaus Deringer LLP has advised Bioeq IP AG on its license and development agreement with Coherus BioSciences, Inc. The agreement enables Coherus to exclusively market…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here